Analysts Viewpoint UroGen Pharma Ltd [URGN] Shares Rise 4.25% on Thursday Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. UroGen Pharma
Analysts Viewpoint URGN’s short interest reaches 7.02 million shares on 2025-08-29 Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. UroGen Pharma
Insiders Updates Chief Medical Officer Schoenberg Mark sold 10,000 shares of UroGen Pharma Ltd [URGN] The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Insiders Updates Taking a Closer Look At UroGen Pharma Ltd (URGN) Following Its Recent Trade UroGen Pharma Ltd’s recently made public that its Officer Schoenberg Mark acquired Company’s shares for reported $97574.0 on Jul 28